Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression.
Cholin L, Ashour T, Mehdi A, Taliercio JJ, Daou R, Arrigain S, Schold JD, Thomas G, Nally J, Nakhoul NL, Nakhoul GN.
Cholin L, et al. Among authors: nakhoul nl.
BMC Nephrol. 2021 Jul 15;22(1):264. doi: 10.1186/s12882-021-02449-0.
BMC Nephrol. 2021.
PMID: 34266395
Free PMC article.